Skip to content
sellModerate cluster of 310b5-1 plan

Charles F Wagner Jr sold $1.6M of VRTX

EVP & Chief Financial Officer at VERTEX PHARMACEUTICALS INC / MA. 3,000 shares at an average of $518.27, traded Nov 11, 2024, filed Nov 13, 2024.

Warning score
42
Value
$1.6M
3,000 shares
Holdings after
44,137
-6% from before
From 52-week low
+12%
low $448.60, close $501.72
From 52-week high
-3%
high $516.74, as of Nov 11, 2024

Score components

  • Role
    CFO
    +22
  • Trade size
    $1.6M at market
    +25
  • Share of holdings sold
    Sold 6.4% of holdings
    0
  • Cluster
    3 insiders selling within 14 days
    +15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -6.2%, 3m -8.4%, 6m -14.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

VRTXOct 9, 2026 · close 510.08
Since filing Nov 13, 2024: +3.1%SPY +33.3% · excess -30.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000875320-24-000227, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 11, 2024SOpen-market sale
Common Stock10b5-1
-3,000$518.27$1.6M44,137Nov 13, 2024

Related signals

Other insiders at VERTEX PHARMACEUTICALS INC / MA and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
37Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Duncan McKechnie
EVP, Chief Commercial Officer
$800k
1,541 shares
-12%
32Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Ourania Tatsis
EVP, Chief Reg. & Quality Off.
$787k
1,500 shares
-3%
26Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Joy Liu
EVP and Chief Legal Officer
$416k
828 shares
-4%
24Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$288k
596 shares
-4%
27Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$471k
1,020 shares
-6%
33Weak
VRTXsell 210b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$1.8M
4,062 shares
-19%
25Weak
VRTXsell 210b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$785k
1,745 shares
-8%
18Weak
VRTXsell 210b5-1
VERTEX PHARMACEUTICALS INC / MA
Joy Liu
EVP and Chief Legal Officer
$364k
828 shares
-4%
33Weak
VRTXsell 310b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$888k
1,974 shares
-8%
30Weak
VRTXsell 410b5-1
VERTEX PHARMACEUTICALS INC / MA
Carmen Bozic
EVP and CMO
$614k
1,354 shares
-5%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Charles F Wagner Jr sold $1.6M of VRTX | InsiderTell